ZA95440B - Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family - Google Patents

Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family

Info

Publication number
ZA95440B
ZA95440B ZA95440A ZA95440A ZA95440B ZA 95440 B ZA95440 B ZA 95440B ZA 95440 A ZA95440 A ZA 95440A ZA 95440 A ZA95440 A ZA 95440A ZA 95440 B ZA95440 B ZA 95440B
Authority
ZA
South Africa
Prior art keywords
growth factor
factor receptor
epidermal growth
tyrosine kinases
receptor family
Prior art date
Application number
ZA95440A
Inventor
Alexander James Bridges
David Fry
Robert Meyer
Andrew Mark Thompson
William Alexander Denny
Alan Kraker
Gordon William Rewcastle
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA95440B publication Critical patent/ZA95440B/en

Links

ZA95440A 1994-01-25 1995-01-19 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family ZA95440B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18674594A 1994-01-25 1994-01-25

Publications (1)

Publication Number Publication Date
ZA95440B true ZA95440B (en) 1995-10-10

Family

ID=22686132

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA95440A ZA95440B (en) 1994-01-25 1995-01-19 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family

Country Status (1)

Country Link
ZA (1) ZA95440B (en)

Similar Documents

Publication Publication Date Title
MD960217A (en) Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
HU9602016D0 (en) Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
ZA95441B (en) Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
PL331221A1 (en) Heteroaromatic bicyclic compounds as inhibitors of propteinous tyrosine kinase
PL331154A1 (en) Bicyclic heteroaromatic compounds as inhibitors of proteinous tyrosine kinase
AU5180493A (en) HER4 human receptor tyrosine kinase
AU7289696A (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
IL137041A0 (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
IL97872A0 (en) Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit egf receptor tyrosine kinase
IL123124A0 (en) Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
IL128505A0 (en) Process for the preparation of pyrimidine compounds
HUP9903506A3 (en) Use of griseofulvin for inhibiting the growth of cancers
ZA974233B (en) Compounds for and methods of inhibiting the association of the platelet-derived growth factor receptor and phosphatidylinositol 3-kinase.
ZA95440B (en) Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
ZA945372B (en) Tyrosine kinase receptor
IL115642A0 (en) Her4 human receptor tyrosine kinase
EP0800531A4 (en) Novel receptor tyrosine kinases
GB9524131D0 (en) Pyrido-pyrimidine compounds as tyrosine kinase inhibitors
GB9510574D0 (en) Novel receptor tyrosine kinases
TW375926U (en) Adjustment structure for the filter of the pot
IL110384A0 (en) Tyrosine kinase receptor